---
schema_version: "secwatch.filing_event.v1"
accession: "0001837607-26-000018"
form_type: "8-K"
ticker: "AEON"
cik: "0001837607"
company_name: "AEON Biopharma, Inc."
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:26:24.157293+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AEON Biopharma reports positive biosimilarity data for ABP-450, raises $6M PIPE, reduces debt 90%

## Summary
- Initial analytical results confirm 100% amino-acid sequence match to BOTOX and highly similar functional characteristics.
- FDA BPD Type 2a meeting provided clear framework for remaining analytical comparability program; majority to be completed in 2026.
- Completed $6M PIPE financing and Daewoong note exchange, reducing outstanding debt by more than 90%.
- Appointed John Bencich as CFO; cash of $3.0M at Dec 31, 2025 plus $4.2M Jan PIPE proceeds expected to fund ops into Q3 2026.

## SEC filing metadata
- accession: 0001837607-26-000018
- form_type: 8-K
- ticker: AEON
- cik: 0001837607
- company_name: AEON Biopharma, Inc.
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1837607/000183760726000018/0001837607-26-000018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1837607/000183760726000018/aeon-20260330x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001837607-26-000018
- JSON: https://secwatch.observer/filing/0001837607-26-000018.json
- Plain text: https://secwatch.observer/filing/0001837607-26-000018.txt

## Key facts
- Earnings Releases
  AEON Biopharma, Inc. reported financial results for the year ended December 31, 2025.
  - Period: the year ended December 31, 2025
  - Result: reported results
  source text: On March 30, 2026, AEON Biopharma, Inc. (the “Company” or “AEON”) announced financial results for the year ended December 31, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1837607/000183760726000018/0001837607-26-000018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.